AFP and neoplasm: In the CPR group, 11 patients showing tumor recurrence had the median pretransplant levels of AFP of 4.4 ng/mL (25–75 percentiles: 2.4–5.9) and PIVKA-II of 23 mAU/mL (25–75 percentiles: 18–27), which were not different from AFP of 4.2 ng/mL (25–75 percentiles: 2.3–12.1; p = 0.674) and PIVKA-II of 21 mAU/mL (25–75 percentiles: 14–28; p = 0.563) in the other 155 patients without tumor recurrence.